Loading clinical trials...
Loading clinical trials...
Light Exposure Tracker in Alzheimer's Disease.
The purpose of this research study is to investigate the relationship between reminder messages sent via text and compliance with a daily morning light intervention designed to advance the circadian clock. Twenty healthy adults will be recruited to participate in a randomized, cross-over study where daily messages are, or are not, provided to remind participants to carry out the intervention.
Age
55 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Light and Health Research Center
Menands, New York, United States
Start Date
February 22, 2024
Primary Completion Date
August 15, 2024
Completion Date
August 15, 2024
Last Updated
October 14, 2025
20
ACTUAL participants
Light goggles
DEVICE
Daily reminder test message
BEHAVIORAL
Lead Sponsor
Icahn School of Medicine at Mount Sinai
NCT06159673
NCT07220668
NCT07457138
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions